New hope for COPD breathing? inhaled drug trial seeks to boost oxygen
NCT ID NCT07037836
Summary
This study is testing whether an inhaled medication called Tyvaso can improve how well the lungs deliver oxygen to the blood in people with COPD and low blood oxygen levels. Ten participants will use the Tyvaso nebulizer four times a day for four weeks. Researchers will use a special type of MRI scan before and after treatment to see if the drug increases blood flow and oxygen exchange in the lungs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOXEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke Asthma Allergy and Airway Center
RECRUITINGDurham, North Carolina, 27705, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.